FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy

Takashi Yoshioka; Hiroshi Fukuda; Takehiko Fujiwara; Ren Iwata; Tatuo Ido; Yasuko Murakawa; Makio Gamo; Chikashi Ishioka; Ryunosuke Kanamaru

doi:10.1097/00003072-199904000-00009

FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy

Takashi Yoshioka, Hiroshi Fukuda, Takehiko Fujiwara, Ren Iwata, Tatuo Ido, Yasuko Murakawa, Makio Gamo, Chikashi Ishioka, Ryunosuke Kanamaru

MED - Medical Sciences

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.

Original language	English
Pages (from-to)	261-263
Number of pages	3
Journal	Clinical Nuclear Medicine
Volume	24
Issue number	4
DOIs	https://doi.org/10.1097/00003072-199904000-00009
Publication status	Published - 1999 Apr

Keywords

Chemotherapy
Fluorine-18-2-deoxy-2-fluoro-D-glucose
Positron Emission Tomography
Recurrence
Residue

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00003072-199904000-00009

Cite this

@article{4d4602faee5e4dee82b456efdfb58423,

title = "FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy",

abstract = "Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.",

keywords = "Chemotherapy, Fluorine-18-2-deoxy-2-fluoro-D-glucose, Positron Emission Tomography, Recurrence, Residue",

author = "Takashi Yoshioka and Hiroshi Fukuda and Takehiko Fujiwara and Ren Iwata and Tatuo Ido and Yasuko Murakawa and Makio Gamo and Chikashi Ishioka and Ryunosuke Kanamaru",

year = "1999",

month = apr,

doi = "10.1097/00003072-199904000-00009",

language = "English",

volume = "24",

pages = "261--263",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy

AU - Yoshioka, Takashi

AU - Fukuda, Hiroshi

AU - Fujiwara, Takehiko

AU - Iwata, Ren

AU - Ido, Tatuo

AU - Murakawa, Yasuko

AU - Gamo, Makio

AU - Ishioka, Chikashi

AU - Kanamaru, Ryunosuke

PY - 1999/4

Y1 - 1999/4

N2 - Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.

AB - Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.

KW - Chemotherapy

KW - Fluorine-18-2-deoxy-2-fluoro-D-glucose

KW - Positron Emission Tomography

KW - Recurrence

KW - Residue

UR - http://www.scopus.com/inward/record.url?scp=0032950533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032950533&partnerID=8YFLogxK

U2 - 10.1097/00003072-199904000-00009

DO - 10.1097/00003072-199904000-00009

M3 - Article

C2 - 10466523

AN - SCOPUS:0032950533

VL - 24

SP - 261

EP - 263

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 4

ER -

FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this